Human placenta: A source of progenitor/stem cells?

Journal fur Reproduktionsmedizin und Endokrinologie

Volumn 3, Issue 2, 2006, Pages 117-126

  Parolini, O ^a   Soncini, M ^a  

^a Fondazione Poliambulanza Istituto Ospedaliero   (Italy)

Author keywords

Amnion; Chorion; Fetal membranes; Mesenchymal cells; Placenta; Stem cells

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; AMNION; CHORION; EXPERIMENTAL MODEL; FETUS MEMBRANE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MESENCHYME CELL; MORPHOLOGICAL TRAIT; NONHUMAN; PLACENTA; REGENERATIVE MEDICINE; REVIEW; STEM CELL; TISSUE ENGINEERING;

EID: 33744963779     PISSN: 18102107     EISSN: 18109292     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Parker MA, Cotanche DA. The potential use of stem cells for cochlear repair. Audiol Neurootol 2004; 9: 72-80.
2. Moore KL, Persaud TVN. Formation of bilaminar embryonic disc and chorionic sac: the second week. In: Moore KL, Persaud TVN (eds). The developing human: clinically oriented embryology. W.B. Saunders Company, Philadelphia, PA, 1998; 47-62.
3. Casey ML, MacDonald PC. Interstitial collagen synthesis and processing in human amnion: a property of the mesenchymal cells. Biol Reprod 1996; 55: 1253-60.
4. Paradowska E, Blach-Olszewska Z, Gejdel E. Constitutive and induced cytokine production by human placenta and amniotic membrane at term. Placenta 1997; 18: 441-6.
5. Tahara M, Tasaka K, Masumoto N, Adachi K, Adachi H, Ikebuchi Y, Kurachi H, Miyake A. Expression of messenger ribonucleic acid for epidermal growth factor (EGF), transforming growth factor-alpha (TGF alpha), and EGF receptor in human amnion cells: possible role of TGF alpha in prostaglandin E2 synthesis and cell proliferation. J Clin Endocrinol Metab 1995; 80: 138-46.
6. Keelan JA, Sato T, Mitchell MD. Interleukin (IL)-6 and IL-8 production by human amnion: regulation by cytokines, growth factors, glucocorticoids, phorbol esters, and bacterial lipopolysaccharide. Biol Reprod 1997; 57: 1438-44.
7. Blumenstein M, Hansen WR, Deval D, Mitchell MD. Differential regulation in human amnion epithelial and fibroblast cells of prostaglandin E(2) production and prostaglandin H synthase-2 mRNA expression by dexamethasone but not tumour necrosis factor-alpha. Placenta 2000; 21: 210-7.
8. Whittle WL, Gibb W, Challis JR. The characterization of human amnion epithelial and mesenchymal cells: the cellular expression, activity and glucocorticoid regulation of prostaglandin output. Placenta 2000; 21: 394-401.
9. Casey ML, MacDonald PC. Keratinocyte growth factor expression in the mesenchymal cells of human amnion. J Clin Endocrinol Metab 1997; 82: 3319-23.
10. Marchese C, Rubin J, Ron D, Faggioni A, Torrisi MR, Messina A, Frati L, Aaronson SA. Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J Cell Physiol 1990; 144: 326-32.
11. Davis JW. Skin transplantation with a review of 550 cases at the Johns Hopkins Hospital. Johns Hopkins Med J 1910; 15: 307-96.
12. Trelford JD, Trelford-Sauder M. The amnion in surgery, past and present. Am J Obstet Gynecol 1979; 134: 833-46.
13. rd, Greene AE, Matheson DW, Lynch D. Human amniotic membrane as a physiologic wound dressing. Arch Surg 1974; 109: 370-3.
14. Faulk WP, Matthews R, Stevens PJ, Bennett JP, Burgos H, Hsi BL. Human amnion as an adjunct in wound healing. Lancet 1980; 1: 1156-8.
15. Subrahmanyam M. Amniotic membrane as a cover for microskin grafts. Br J Plast Surg 1995; 48: 477-8.
16. Gruss JS, Jirsch DW. Human amniotic membrane: a versatile wound dressing. Can Med Assoc J 1978; 118: 1237-46.
17. Ward DJ, Bennett JP. The long-term results of the use of human amnion in the treatment of leg ulcers. Br J Plast Surg 1984; 37: 191-3.
18. Ward DJ, Bennett JP, Burgos H, Fabre J. The healing of chronic venous leg ulcers with prepared human amnion. Br J Plast Surg 1989; 42: 463-7.
19. Gomes JA, Romano A, Santos MS, Dua HS. Amniotic membrane use in ophthalmology. Curr Opin Ophthalmol 2005; 16: 233-40.
20. Miyamoto K, Hayashi K, Suzuki T, Ichihara S, Yamada T, Kano Y, Yamabe T, Ito Y. Human placenta feeder layers support undifferentiated growth of primate embryonic stem cells. Stem Cells 2004; 22: 433-40.
21. Koizumi N, Fullwood NJ, Bairaktaris G, Inatomi T, Kinoshita S, Quantock AJ. Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane. Invest Ophthalmol Vis Sci 2000; 41: 2506-13.
22. Talmi YP, Sigler L, Inge E, Finkelstein Y, Zohar Y. Antibacterial properties of human amniotic membranes. Placenta 1991; 12: 285-8.
23. Tseng SC, Li DQ, Ma X. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol 1999; 179: 325-35.
24. Kim JS, Kim JC, Na BK, Jeong JM, Song CY. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res 2000; 70: 329-37.
25. Tseng SC, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 1998; 116: 431-41.
26. Bilic G, Ochsenbein-Kolble N, Hall H, Huch R, Zimmermann R. In vitro lesion repair by human amnion epithelial and mesenchymal cells. Am J Obstet Gynecol 2004; 190: 87-92.
27. Matikainen T, Laine J. Placenta-an alternative source of stem cells. Toxicol Appl Pharmacol 2005; 207: 544-9.
28. Yen BL, Huang HI, Chien CC, Jui HY, Ko BS, Yao M, Shun CT, Yen ML, Lee MC, Chen YC. Isolation of multipotent cells from human term placenta. Stem Cells 2005; 23: 3-9.
29. In 't Anker PS, Scherjon SA, Kleijburg-Van der Keur C, De Groot-Swings GM, Claas FH, Fibbe WE, Kanhai HH. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004; 22: 1338-45.
30. Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004; 22: 649-58.
31. Bailo M, Soncini M, Vertua E, Signoroni PB, Sanzone S, Lombardi G, Arienti D, Calamani F, Zatti D, Paul P, Albertini A, Zorzi F, Cavagnini A, Candotti F, Wengler GS, Parolini O. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 2004; 78: 1439-48.
32. Sakuragawa N, Thangavel R, Mizuguchi M, Hirasawa M, Kamo I. Expression of markers for both neuronal and glial cells in human amniotic epithelial cells. Neurosci Lett 1996; 209: 9-12.
33. Sakuragawa N, Misawa H, Ohsugi K, Kakishita K, Ishii T, Thangavel R, Tohyama J, Elwan M, Yokoyama Y, Okuda O, Arai H, Ogino I, Sato K. Evidence for active acetylcholine metabolism in human amniotic epithelial cells: applicable to intracerebral allografting for neurologic disease. Neurosci Lett 1997; 232: 53-6.
34. Elwan MA, Sakuragawa N. Evidence for synthesis and release of catecholamines by human amniotic epithelial cells. Neuroreport 1997; 8: 3435-8.
35. Ishii T, Ohsugi K, Nakamura S, Sato K, Hashimoto M, Mikoshiba K, Sakuragawa N. Gene expression of oligodendrocyte markers in human amniotic epithelial cells using neural cell-type-specific expression system. Neurosci Lett 1999; 268: 131-4.
36. Uchida S, Inanaga Y, Kobayashi M, Hurukawa S, Araie M, Sakuragawa N. Neurotrophic function of conditioned medium from human amniotic epithelial cells. J Neurosci Res 2000; 62: 585-90.
37. Kosuga M, Takahashi S, Sasaki K, Enosawa S, Li XK, Okuyama S, Fujino M, Suzuki S, Yamada M, Matsuo N, Sakuragawa N, Okuyama T. Phenotype correction in murine mucopolysaccharidosis type VII by transplantation of human amniotic epithelial cells after adenovirus-mediated gene transfer. Cell Transplant 2000; 9: 687-92.
38. Kosuga M, Takahashi S, Tanabe A, Fujino M, Li XK, Suzuki S, Yamada M, Kakishita K, Ono F, Sakuragawa N, Okuyama T. Widespread distribution of adenovirus-transduced monkey amniotic epithelial cells after local intracerebral injection: implication for cell-mediated therapy for lysosome storage disorders. Cell Transplant 2001; 10: 435-9.
39. Kakishita K, Elwan MA, Nakao N, Itakura T, Sakuragawa N. Human amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson's disease: a potential source of donor for transplantation therapy. Exp Neurol 2000; 165: 27-34.
40. Koyano S, Fukui A, Uchida S, Yamada K, Asashima M, Sakuragawa N. Synthesis and release of activin and noggin by cultured human amniotic epithelial cells. Dev Growth Differ 2002; 44: 103-12.
41. Takahashi N, Enosawa S, Mitani T, Lu H, Suzuki S, Amemiya H, Amano T, Sakuragawa N. Transplantation of amniotic epithelial cells into fetal rat liver by in utero manipulation. Cell Transplant 2002; 11: 443-9.
42. Elwan MA, Ishii T, Sakuragawa N. Characterization of dopamine D2 receptor gene expression and binding sites in human placenta amniotic epithelial cells. Placenta 2003; 24: 658-63.
43. Elwan MA, Ishii T, Sakuragawa N. Evidence of dopamine D1 receptor mRNA and binding sites in cultured human amniotic epithelial cells. Neurosci Lett 2003; 344: 157-60.
44. Elwan MA, Ishii T, Sakuragawa N. Characterization of the dopamine transporter gene expression and binding sites in cultured human amniotic epithelial cells. Neurosci Lett 2003; 342: 61-4.
45. Sakuragawa N, Kakinuma K, Kikuchi A, Okano H, Uchida S, Kamo I, Kobayashi M, Yokoyama Y. Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells. J Neurosci Res 2004; 78: 208-14.
46. Zhao P, Ise H, Hongo M, Ota M, Konishi I, Nikaido T. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 2005; 79: 528-35.
47. Prusa AR, Marton E, Rosner M, Bernaschek G, Hengstschläger M. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod 2003; 18: 1489-93.
48. In 't Anker PS, Scherjon SA, Kleijburg-Van der Keur C, Noort WA, Claas FH, Willemze R, Fibbe WE, Kanhai HH. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003; 102: 1548-9.
49. Tsai MS, Lee JL, Chang YJ, Hwang SM. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004; 19: 1450-6.
50. Sartore S, Lenzi M, Angelini A, Chiavegato A, Gasparotto L, De Coppi P, Bianco R, Gerosa G. Amniotic mesenchymal cells auto-transplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes. Eur J Cardiothorac Surg 2005; 28: 677-84.
51. Miki T, Lehmann T, Cai H, Stolz DB, Strom SC. Stem cell characteristics of amniotic epithelial cells. Stem Cells 2005; 23: 1549-59.
52. Kakishita K, Nakao N, Sakuragawa N, Itakura T. Implantation of human amniotic epithelial cells prevents the degeneration of nigral dopamine neurons in rats with 6-hydroxydopamine lesions. Brain Res 2003; 980: 48-56.
53. Sankar V, Muthusamy R. Role of human amniotic epithelial cell transplantation in spinal cord injury repair research. Neuroscience 2003; 118: 11-7.
54. Wei JP, Zhang TS, Kawa S, Aizawa T, Ota M, Akaike T, Kato K, Konishi I, Nikaido T. Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplant 2003; 12: 545-52.
55. Sakuragawa N, Enosawa S, Ishii T, Thangavel R, Tashiro T, Okuyama T, Suzuki S. Human amniotic epithelial cells are promising transgene carriers for allogeneic cell transplantation into liver. J Hum Genet 2000; 45: 171-6.
56. Takashima S, Ise H, Zhao P, Akaike T, Nikaido T. Human amniotic epithelial cells possess hepatocyte-like characteristics and functions. Cell Struct Funct 2004; 29: 73-84.
57. Okawa H, Okuda O, Arai H, Sakuragawa N, Sato K. Amniotic epithelial cells transform into neuron-like cells in the ischemic brain. Neuroreport 2001; 12: 4003-7.
58. Elwan MA, Thangavel R, Ono F, Sakuragawa N. Synthesis and release of catecholamines by cultured monkey amniotic epithelial cells. J Neurosci Res 1998; 53: 107-13.
59. Elwan MA, Ishii T, Sakuragawa N. Detection of dopamine D2 receptor mRNA and binding sites in monkey amniotic epithelial cells. J Neurosci Res 1999; 56: 316-22.
60. Zhang Y, Li C, Jiang X, Zhang S, Wu Y, Liu B, Tang P, Mao N. Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells. Exp Hematol 2004; 32: 657-64.
61. Wulf GG, Viereck V, Hemmerlein B, Haase D, Vehmeyer K, Pukrop T, Glass B, Emons G, Trumper L. Mesengenic progenitor cells derived from human placenta. Tissue Eng 2004; 10: 1136-47.
62. Igura K, Zhang X, Takahashi K, Mitsuru A, Yamaguchi S, Takashi TA. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy 2004; 6: 543-53.
63. Li CD, Zhang WY, Li HL, Jiang XX, Zhang Y, Tang P, Mao N. Isolation and identification of a multilineage potential mesenchymal cell from human placenta. Placenta 2005; Epub ahead of print.
64. Zhang X, Mitsuru A, Igura K, Takahashi K, Ichinose S, Yamaguchi S, Takahashi TA. Mesenchymal progenitor cells derived from chorionic villi of human placenta for cartilage tissue engineering. Biochem Biophys Res Commun 2006; 340: 944-52.
65. Tsai MS, Hwang SM, Tsai YL, Cheng FC, Lee JL, Chang YJ. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 2006; 74: 545-51.
66. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
67. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-9.
68. Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 2001; 189: 54-63.
69. Villaron EM, Almeida J, Lopez-Holgado N, Alcoceba M, Sanchez-Abarca LI, Sanchez-Guijo FM, Alberca M, Perez-Simon JA, San Miguel JF, Del Canizo MC. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Haematologica 2004; 89: 1421-7.
70. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000; 109: 235-42.
71. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998; 176: 57-66.
72. Kemp KC, Hows J, Donaldson C. Bone marrow-derived mesenchymal stem cells. Leuk Lymphoma 2005; 46: 1531-44.
73. Barry FP, Murphy JM, English K, Mahon BP. Immunogenicity of adult mesenchymal stem cells: lessons from the fetal allograft. Stem Cells Dev 2005; 14: 252-65.
74. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-22.
75. Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, Mao N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005; 105: 4120-6.
76. Le Blanc K, Pittenger M. Mesenchymal stem cells: progress toward promise. Cytotherapy 2005; 7: 36-45.
77. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999; 14: 1115-22.
78. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001; 98: 2396-402.
79. In 't Anker PS, Noort WA, Scherjon SA, Kleijburg-Van der Keur C, Kruisselbrink AB, Van Bezooijen RL, Beekhuizen W, Willemze R, Kanhai HH, Fibbe WE. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 2003; 88: 845-52.
80. Tondreau T, Lagneaux L, Dejeneffe M, Delforge A, Massy M, Mortier C, Bron D. Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential. Cytotherapy 2004; 6: 372-9.
81. Hunt JS, Robertson SA. Uterine macrophages and environmental programming for pregnancy success. J Reprod Immunol 1996; 32: 1-25.
82. Redline RW. The structural basis of maternal-fetal immune interactions in the human placenta. Curr Top Microbiol Immunol 1997; 222: 25-44.
83. Torry DS, McIntyre JA, Faulk WP. Immunobiology of the trophoblast: mechanisms by which placental tissues evade maternal recognition and rejection. Curr Top Microbiol Immunol 1997; 222: 127-40.
84. Yokoyama WM. The mother-child union: the case of missing-self and protection of the fetus. Proc Natl Acad Sci USA 1997; 94: 5998-6000.
85. Mellor AL, Munn DH. Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol 2000; 18: 367-91.
86. Kubo M, Sonoda Y, Muramatsu R, Usui M. Immunogenicity of human amniotic membrane in experimental xenotransplantation. Invest Ophthalmol Vis Sci 2001; 42: 1539-46.
87. Allan DS, Lepin EJ, Braud VM, O'Callaghan CA, McMichael AJ. Tetrameric complexes of HLA-E, HLA-F, and HLA-G. J Immunol Methods 2002; 268: 43-50.
88. Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan CA, Dunbar R, Ogg GS, Cerundolo V, Rolink A. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998; 160: 3096-100.
89. Llano M, Lee N, Navarro F, Garcia P, Albar JP, Geraghty DE, Lopez-Botet M. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur J Immunol 1998; 28: 2854-63.
90. Fournel S, Aguerre-Girr M, Huc X, Lenfant F, Alam A, Toubert A, Bensussan A, Le Bouteiller P. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000; 164: 6100-4.
91. Bainbridge DR, Ellis SA, Sargent IL. HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol 2000; 48: 17-26.
92. Djian V, Menu E, Thibault G, Ropert S, Chaouat G. Immunoactive products of placenta. V. Immunoregulatory properties of a low molecular weight compound obtained from human placental cultures. Am J Reprod Immunol 1996; 36: 11-24.
93. De Smedt D, Menu E, Chaouat G. Immunoactive products of placenta. VI. Induction of transient murine T cell anergy by a low-molecular-weight compound obtained from supernatants of human placental cultures. Cell Immunol 1997; 175: 128-40.
94. Ueta M, Kweon MN, Sano Y, Sotozono C, Yamada J, Koizumi N, Kiyono H, Kinoshita S. Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction. Clin Exp Immunol 2002; 129: 464-70.
95. Li CD, Zhang WY, Li HL, Jiang XX, Zhang Y, Tang PH, Mao N. Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation. Cell Res 2005; 15: 539-47.
96. Heeger PS. Amnion and chorion cells as therapeutic agents for transplantation and tissue regeneration: a field in its infancy. Transplantation 2004, 78: 1411-2.